Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life science company can thrive in Switzerland’s ecosystem. 

Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquarters or regional centers overseeing operations in Europe and EMEA. Its central location, business-friendliness, competitive corporate and personal taxes, and diverse talent pool make it an attractive option. Companies like Merck Serono, Takeda Pharmaceuticals, Biogen or Johnson & Johnson chose to do so. What about you?

Are you looking for skilled personnel in the Life Science industry? Switzerland is famous for its highly qualified workforce. Find out how your Life Sciences company can benefit from Switzerland’s vast talent pool.  

Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn how your company can benefit from Switzerland’s unique focus on applied science. 

Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your life science company. 

The life sciences company Ariceum Therapeutics has established a subsidiary in Basel. This spin-off has received support from Basel Area Business & Innovation. Germo Gericke from Novartis was named Chief Medical Officer.

Microalgae open up new possibilities for food and medicine. From its base in Switzerland, the mission of YIS is to find promising biotechnology fields and work on research activities with members in Europe, Japan, India, and other countries to develop new biobusiness areas. 

UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art facility in the Swiss canton of Fribourg for the production of allergy, neurology (CNS) and immunology drugs. We talked with Nicolas Tièche, Head of Bulle Site at UCB about their history with Switzerland, as well as trends and challenges in biopharmaceutical production.

Incepto Medical is a Paris-based company that co-creates and distributes AI apps for medical imaging. Their goal is to be the “Netflix of medical imaging” at a European level. To intensify their partnership with the Swiss imaging company 3R and to have access to the ecosystem, the successful start-up has set up office in the Canton of Vaud this year. 

For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in the manufacture of medications for treating immune deficiencies and disorders of the immune function, as well as medications for rhesus prophylaxis and albumin solutions for shock and burn victims. In the interview with us, Martin Schären, Senior VP and General Manager of CSL Behring AG in Bern, explains how the company continues to innovate and deliver life-saving medicines.

Switzerland is an important hub for the life sciences industry. It is the second largest exporter of packaged medicines in the world and home to more than 70 major pharma global or regional headquarters. Patricia Gee, who leads Deloitte’s Future of Health initiative, talks about the innovative environment companies find here and latest developments in the field of personalized health. 

Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing facilities, and in the last two years the company has invested a further EURO 418 million in new production capacity. Christiane von der Eltz, General Manager and Managing Director at Merck Switzerland AG, talks with us about why Merck regards Switzerland as a strong, strategic, and ever more attractive location for biotech.